translated from Spanish: Uruguay to defer to nearly two months the second dose of the Pfizer vaccine

Like several countries, Uruguay decided to defer the second application of the Pfizer coronavirus vaccine to over 80, adults in asylums and health workers. The deadline would be “a period of 42 to 56 days” in which priority will be given to adults between 71 and 79, who, in the words of the immunologist and member of the National Commission of Vaccination Adviser Alejandro Chabalgoity, were “falling back”.

This decision is also part of the slow delivery of the two million doses with which Uruguay was endowed with inoculants. Today, the country only has 10% of the doses arranged with the U.S. lab. This concerns the Uruguayan authorities, who were forced to consider a new way in which to administer vaccines to avoid as many deaths as possible as part of this start to the second wave of COVID-19 that the country is suffering. Uruguay’s vaccination plan began on 1 March with the doses provided by CoronaVac, developed by Sinovac Biotech, and the country has already vaccinated just over 500,000 people, representing 15% of its total population.

Original source in Spanish